Press Release | Wed Mar 27, 2013 8:03am EDT

Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee for Pivotal Phase lll Clinical Trial for Firdapse(TM)

* Reuters is not responsible for the content in this press release.